Fastest Growing Canadian Companies by Revenue — Health Care
Canadian companies ranked by year-over-year revenue growth.
Updated September 23, 2026200 companiesTotal market cap $557.3B
Showing 200 companies (CDRs hidden)
| Rank | Company | Symbol | Market Cap | Revenue (TTM) | Revenue Growth (YoY) |
|---|---|---|---|---|---|
| 1 | Axe Compute Inc. | AGPU:US | $146M | $3M | 119772.90% |
| 2 | Precision BioSciences Inc | DTIL:US | $198M | $45M | 37272.40% |
| 3 | 4D Molecular Therapeutics Inc | FDMT:US | $842M | $92M | 25106.70% |
| 4 | Septerna, Inc. Common Stock | SEPN:US | $1.9B | $99M | 22375.60% |
| 5 | Vir Biotechnology Inc | VIR:US | $1.8B | $303M | 19582.50% |
| 6 | Nakamoto Inc. | NAKA:US | $180M | $28M | 8680.10% |
| 7 | MeiraGTx Holdings PLC | MGTX:US | $1.2B | $398M | 8608.60% |
| 8 | Adagene Inc | ADAG:US | $216M | $9M | 7332.80% |
| 9 | Precigen Inc | PGEN:US | $2.8B | $86M | 6322.70% |
| 10 | Helius Medical Technologies Inc Class A | HSDT:US | $188M | $12M | 5774.40% |
| 11 | Connect Biopharma Holdings Ltd | CNTB:US | $83M | $3M | 5666.70% |
| 12 | Aethlon Medical Inc | AEMD:US | $5M | $574,245 | 4278.20% |
| 13 | Therma Bright Inc | THRM:V | $3M | $135,824 | 3771.40% |
| 14 | Protagonist Therapeutics Inc | PTGX:US | $9.4B | $282M | 3749.20% |
| 15 | Aligos Therapeutics Inc | ALGS:US | $35M | $32M | 2778.50% |
| 16 | Abeona Therapeutics Inc | ABEO:US | $324M | $26M | 2745.00% |
| 17 | Janux Therapeutics Inc | JANX:US | $1.0B | $24M | 2177.90% |
| 18 | CG Oncology, Inc. Common stock | CGON:US | $6.9B | $6M | 1982.70% |
| 19 | HCW Biologics Inc | HCWB:US | $4M | $7M | 1969.70% |
| 20 | Liquidia Technologies Inc | LQDA:US | $6.1B | $451M | 1842.70% |
| 21 | Verastem Inc | VSTM:US | $724M | $88M | 1775.40% |
| 22 | Hyperion DeFi, Inc. | HYPD:US | $60M | $1M | 1559.50% |
| 23 | Pasithea Therapeutics Corp | KTTA:US | $17M | $486,559 | 1498.10% |
| 24 | Praxis Precision Medicines Inc | PRAX:US | $8.4B | $7M | 1349.10% |
| 25 | AC Immune Ltd | ACIU:US | $264M | $18M | 1057.20% |
| 26 | Crispr Therapeutics AG | CRSP:US | $5.6B | $13M | 1041.40% |
| 27 | Arvinas Inc | ARVN:US | $549M | $317M | 1014.70% |
| 28 | Moolec Science SA Ordinary Shares | MLEC:US | $4M | $8M | 948.30% |
| 29 | Exicure Inc | XCUR:US | $8M | - | 928.00% |
| 30 | Rani Therapeutics Holdings Inc | RANI:US | $111M | $5M | 893.00% |
| 31 | KDA Group Inc | KDA:V | $15M | $419,129 | 791.20% |
| 32 | Bio Green Med Solution, Inc. | BGMS:US | $6M | $2M | 710.00% |
| 33 | Virax Biolabs Group Limited Ordinary Shares | VRAX:US | $2M | $12,423 | 684.90% |
| 34 | Immutep Ltd ADR | IMMP:US | $42M | $20M | 633.50% |
| 35 | Tonix Pharmaceuticals Holding Corp | TNXP:US | $184M | $29M | 577.90% |
| 36 | Bullfrog AI Holdings, Inc. Common Stock | BFRG:US | $11M | $298,798 | 547.60% |
| 37 | VistaGen Therapeutics Inc | VTGN:US | $10M | $3M | 504.90% |
| 38 | Dare Bioscience Inc | DARE:US | $16M | $1M | 499.60% |
| 39 | Nyxoah | NYXH:US | $151M | $22M | 472.80% |
| 40 | Kymera Therapeutics Inc | KYMR:US | $9.7B | $105M | 466.40% |
| 41 | PAVmed Inc | PAVM:US | $39M | $112,000 | 450.00% |
| 42 | Scienture Holdings, Inc. | SCNX:US | $12M | $821,315 | 449.10% |
| 43 | Hydreight Technologies Inc | NURS:V | $171M | $78M | 421.40% |
| 44 | Altimmune Inc | ALT:US | $636M | $31,000 | 420.00% |
| 45 | Surrozen Inc | SRZN:US | $194M | $12M | 408.60% |
| 46 | Regenxbio Inc | RGNX:US | $520M | $174M | 405.70% |
| 47 | Mesoblast Ltd | MESO:US | $2.0B | $120M | 390.70% |
| 48 | Apollomics Inc. Class A Ordinary Shares | APLM:US | $69M | $9M | 380.80% |
| 49 | MacroGenics Inc | MGNX:US | $262M | $175M | 378.00% |
| 50 | X4 Pharmaceuticals Inc | XFOR:US | $340M | $16M | 346.30% |
| 51 | Pharmacielo Ltd | PCLO:V | $11M | $4M | 331.00% |
| 52 | YD Bio Ltd | YDES:US | $186M | $1M | 314.90% |
| 53 | Kazia Therapeutics Ltd ADR | KZIA:US | $125M | $2M | 312.40% |
| 54 | MedMira Inc | MIR:V | $46M | $370,568 | 308.00% |
| 55 | Sinovac Biotech Ltd | SVA:US | $642M | $511M | 303.70% |
| 56 | Insmed Inc | INSM:US | $26.4B | $1.1B | 296.10% |
| 57 | Atea Pharmaceuticals Inc | AVIR:US | $436M | $192M | 295.20% |
| 58 | Dianthus Therapeutics Inc. | DNTH:US | $5.4B | $2M | 294.30% |
| 59 | Viridian Therapeutics Inc | VRDN:US | $2.4B | $71M | 278.70% |
| 60 | Alpha Cognition Inc | ACOG:US | $195M | $15M | 267.60% |
| 61 | Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | CUPR:US | $14M | $49,894 | 267.40% |
| 62 | Agios Pharm | AGIO:US | $2.0B | $98M | 259.30% |
| 63 | INmune Bio Inc | INMB:US | $60M | - | 257.10% |
| 64 | OmniAb Inc. | OABI:US | $715M | $38M | 244.20% |
| 65 | MediciNova Inc | MNOV:US | $162M | $920,481 | 240.60% |
| 66 | Clene Inc. | CLNN:US | $65M | $197,000 | 233.30% |
| 67 | Editas Medicine Inc | EDIT:US | $435M | $47M | 232.30% |
| 68 | SINTX Technologies Inc | SINT:US | $12M | $1M | 199.30% |
| 69 | UroGen Pharma Ltd | URGN:US | $2.1B | $189M | 199.20% |
| 70 | Silence Therapeutics PLC | SLN:US | $764M | $615,000 | 197.20% |
| 71 | Nanobiotix | NBTX:US | $1.8B | $33M | 186.80% |
| 72 | Adlai Nortye Ltd. American Depositary Shares | ANL:US | $1.1B | $18M | 178.10% |
| 73 | Taysha Gene Therapies Inc | TSHA:US | $1.6B | $5M | 171.30% |
| 74 | Arrowhead Pharmaceuticals Inc | ARWR:US | $10.2B | $669M | 171.00% |
| 75 | Avricore Health Inc | AVCR:V | $8M | $193,041 | 170.40% |
| 76 | Cue Biopharma | CUE:US | $224M | $38M | 166.70% |
| 77 | Healthcare Triangle Inc | HCTI:US | $11M | $26M | 158.40% |
| 78 | CorMedix Inc | CRMD:US | $606M | $462M | 156.50% |
| 79 | ATAI Life Sciences BV | ATAI:US | $2.7B | $4M | 137.00% |
| 80 | Xilio Development Inc | XLO:US | $59M | $64M | 131.20% |
| 81 | Tenon Medical Inc | TNON:US | $2M | $5M | 126.80% |
| 82 | ProQR Therapeutics BV | PRQR:US | $262M | $18M | 120.40% |
| 83 | BridgeBio Pharma Inc | BBIO:US | $13.5B | $713M | 120.40% |
| 84 | Autolus Therapeutics Ltd | AUTL:US | $540M | $117M | 118.40% |
| 85 | Senseonics Holdings, Inc. Common Stock | SENS:US | $517M | $49M | 117.80% |
| 86 | RenovoRx Inc | RNXT:US | $75M | $2M | 115.40% |
| 87 | Ascendis Pharma AS | ASND:US | $15.6B | $1.0B | 114.70% |
| 88 | ARS Pharmaceuticals, Inc | SPRY:US | $446M | $117M | 114.20% |
| 89 | Foghorn Therapeutics Inc | FHTX:US | $246M | $37M | 112.70% |
| 90 | Aktis Oncology, Inc. Common stock | AKTS:US | $1.2B | $10M | 111.40% |
| 91 | STAAR Surgical Company | STAA:US | $1.0B | $340M | 111.00% |
| 92 | Precision Optics Corporation, Inc. Common stock | POCI:US | $50M | $29M | 108.00% |
| 93 | Compugen | CGEN:US | $231M | $74M | 107.00% |
| 94 | Freenome, Inc. Common stock | FRNM:US | $1.8B | $35M | 106.50% |
| 95 | ABVC Biopharma Inc | ABVC:US | $31M | $797,916 | 104.50% |
| 96 | LSL Pharma Group Inc. | LSL:V | $41M | $42M | 102.70% |
| 97 | PTC Therapeutics Inc | PTCT:US | $5.5B | $1.0B | 101.50% |
| 98 | Eton Pharmaceuticals Inc | ETON:US | $1.6B | $106M | 98.60% |
| 99 | Biosyent Inc. | RX:V | $181M | $56M | 95.20% |
| 100 | Immunitybio Inc | IBRX:US | $9.0B | $166M | 93.90% |
| 101 | Immatics NV | IMTX:US | $1.4B | $42M | 93.00% |
| 102 | Syndax Pharmaceuticals Inc | SNDX:US | $1.6B | $252M | 91.80% |
| 103 | iTonic Holdings Ltd. | ITOC:US | $8M | $523,031 | 91.60% |
| 104 | Reliq Health Technologies Inc | RHT:V | $47M | $15M | 88.50% |
| 105 | OneMedNet Corp. | ONMD:US | $39M | $1M | 88.40% |
| 106 | Phathom Pharmaceuticals Inc | PHAT:US | $628M | $240M | 88.00% |
| 107 | Fennec Pharmaceuticals Inc | FRX:TO | $526M | $59M | 85.20% |
| 108 | Fennec Pharmaceuticals Inc | FENC:US | $383M | $59M | 85.20% |
| 109 | Alamar Biosciences, Inc. Common Stock | ALMR:US | $2.4B | $100M | 82.10% |
| 110 | SeaStar Medical Holding Corporation | ICU:US | $16M | $2M | 82.00% |
| 111 | Numinus Wellness Inc | NUMI:TO | $16M | $6M | 81.60% |
| 112 | EUDA Health Holdings Limited | EUDA:US | $52M | $7M | 78.90% |
| 113 | Sera Prognostics Inc | SERA:US | $84M | $70,000 | 76.50% |
| 114 | Adagio Medical Holdings, Inc Common Stock | ADGM:US | $11M | $137,000 | 75.60% |
| 115 | Innovative Eyewear Inc. | LUCY:US | $8M | $3M | 74.50% |
| 116 | Anbio Biotechnology Class A Ordinary Shares | NNNN:US | $245M | $9M | 73.90% |
| 117 | Icecure Medical | ICCM:US | $7M | $4M | 72.80% |
| 118 | Madrigal Pharmaceuticals Inc | MDGL:US | $12.1B | $1.3B | 71.20% |
| 119 | TG Therapeutics Inc | TGTX:US | $8.9B | $800M | 70.30% |
| 120 | Qilian International Holding Group Limited | BGM:US | $103M | $48M | 69.80% |
| 121 | Aequus Pharmaceuticals Inc | AQS:V | $1M | $918,468 | 69.70% |
| 122 | Tarsus Pharmaceuticals Inc | TARS:US | $3.6B | $606M | 69.40% |
| 123 | Basel Medical Group Ltd Ordinary Shares | BMGL:US | $7M | $15M | 67.10% |
| 124 | Capstone Holding Corp. Common Stock | CAPS:US | $4M | $60M | 67.10% |
| 125 | Alnylam Pharmaceuticals Inc | ALNY:US | $32.7B | $4.8B | 66.90% |
| 126 | Iovance Biotherapeutics Inc | IOVA:US | $4.6B | $325M | 65.70% |
| 127 | BillionToOne, Inc. Class A Common Stock | BLLN:US | $4.9B | $397M | 64.40% |
| 128 | Anteris Technologies Global Corp. Common Stock | AVR:US | $792M | $2M | 63.30% |
| 129 | VentriPoint Diagnostics Ltd | VPT:V | $17M | $147,773 | 61.70% |
| 130 | Kestra Medical Technologies, Ltd. Common Stock | KMTS:US | $1.5B | $107M | 59.90% |
| 131 | Sonoma Pharmaceuticals Inc | SNOA:US | $6M | $22M | 59.60% |
| 132 | Extendicare Inc | EXE:TO | $3.0B | $2.0B | 59.40% |
| 133 | Crescita Therapeutics Inc | CTX:TO | $15M | $23M | 59.40% |
| 134 | Arcutis Biotherapeutics Inc | ARQT:US | $3.3B | $464M | 59.30% |
| 135 | argenx NV ADR | ARGX:US | $61.5B | $5.3B | 59.30% |
| 136 | Redhill Biopharma Ltd | RDHL:US | $3M | $286,000 | 58.60% |
| 137 | Cronos Group Inc | CRON:TO | $1.8B | $179M | 58.40% |
| 138 | Cronos Group Inc | CRON:US | $1.3B | $179M | 58.40% |
| 139 | Carlsmed, Inc. | CARL:US | $426M | $63M | 56.70% |
| 140 | Clover Health Investments Corp | CLOV:US | $2.4B | $2.5B | 55.60% |
| 141 | Ideaya Biosciences Inc | IDYA:US | $3.8B | $234M | 55.40% |
| 142 | Kiniksa Pharmaceuticals Ltd | KNSA:US | $6.1B | $841M | 55.40% |
| 143 | Star Equity Holdings Inc | STRR:US | $36M | $210M | 54.60% |
| 144 | Star Equity Holdings Prf | STRRP:US | - | $210M | 54.60% |
| 145 | Zevra Therapeutics Inc. | ZVRA:US | $688M | $136M | 53.30% |
| 146 | Carespan Health Inc | CSPN:V | $1M | $-145,310 | 53.10% |
| 147 | CareDx Inc | CDNA:US | $2.8B | $458M | 52.20% |
| 148 | Pulsenmore Ltd. Ordinary Shares | PLSM:US | $15M | - | 52.00% |
| 149 | Legend Biotech Corp | LEGN:US | $3.6B | $1.3B | 51.90% |
| 150 | OrganiGram Holdings Inc | OGI:US | $160M | $309M | 49.40% |
| 151 | OrganiGram Holdings Inc | OGI:TO | $226M | $309M | 49.40% |
| 152 | Coya Therapeutics, Inc. Common Stock | COYA:US | $124M | $8M | 49.00% |
| 153 | Gelteq Limited Ordinary Shares | GELS:US | $7M | $471,799 | 48.90% |
| 154 | Astrana Health Inc | ASTH:US | $1.7B | $3.8B | 48.50% |
| 155 | Travere Therapeutics Inc | TVTX:US | $5.8B | $591M | 48.20% |
| 156 | Halozyme Therapeutics Inc | HALO:US | $12.6B | $1.7B | 47.70% |
| 157 | Heartflow, Inc. Common Stock | HTFL:US | $4.4B | $212M | 47.60% |
| 158 | CytoMed Therapeutics Limited Ordinary Shares | GDTC:US | $11M | $860,848 | 46.90% |
| 159 | Rhythm Pharmaceuticals Inc | RYTM:US | $6.8B | $240M | 46.90% |
| 160 | Axsome Therapeutics Inc | AXSM:US | $10.8B | $777M | 45.50% |
| 161 | Caris Life Sciences, Inc. Common Stock | CAI:US | $8.7B | $990M | 45.40% |
| 162 | Hyperfine Inc | HYPR:US | $83M | $17M | 44.80% |
| 163 | Guardant Health Inc | GH:US | $23.8B | $1.2B | 44.30% |
| 164 | Omada Health, Inc. Common Stock | OMDA:US | $1.3B | $310M | 43.10% |
| 165 | MannKind Corp | MNKD:US | $1.1B | $394M | 42.90% |
| 166 | Prelude Therapeutics Inc | PRLD:US | $387M | $22M | 41.00% |
| 167 | Coherus BioSciences Inc | CHRS:US | $212M | $51M | 39.50% |
| 168 | Neurocrine Biosciences Inc | NBIX:US | $14.5B | $3.4B | 39.50% |
| 169 | SS Innovations International Inc. Common Stock | SSII:US | $661M | $52M | 39.40% |
| 170 | Assembly Biosciences Inc | ASMB:US | $518M | $75M | 38.90% |
| 171 | EDAP TMS S.A. | FOCL:US | $200M | $79M | 38.80% |
| 172 | Aquestive Therapeutics Inc | AQST:US | $621M | $54M | 38.10% |
| 173 | Mirum Pharmaceuticals Inc | MIRM:US | $6.0B | $618M | 37.90% |
| 174 | Beta Bionics, Inc. Common Stock | BBNX:US | $1.2B | $119M | 37.80% |
| 175 | Incyte Corporation | INCY:US | $25.3B | $5.8B | 37.70% |
| 176 | Natera Inc | NTRA:US | $53.4B | $2.7B | 37.70% |
| 177 | Nano X Imaging Ltd | NNOX:US | $58M | $16M | 36.70% |
| 178 | Kyntra Bio, Inc. | KYNB:US | $29M | $5M | 36.50% |
| 179 | Kura Oncology Inc | KURA:US | $1.0B | $77M | 36.50% |
| 180 | 20/20 Biolabs, Inc. Common Stock | AIDX:US | $6M | $2M | 36.50% |
| 181 | Intelligent Bio Solutions Inc. | INBS:US | $6M | $4M | 35.80% |
| 182 | Pennant Group Inc | PNTG:US | $1.4B | $1.1B | 35.80% |
| 183 | Brainsway Ltd | BWAY:US | $548M | $61M | 35.40% |
| 184 | Humacyte Inc | HUMA:US | $164M | $2M | 34.90% |
| 185 | Vivos Therapeutics Inc | VVOS:US | $3M | $21M | 34.90% |
| 186 | Quanterix Corp | QTRX:US | $151M | $153M | 34.40% |
| 187 | Agenus Inc | AGEN:US | $376M | $133M | 34.40% |
| 188 | Biodesix Inc | BDSX:US | $300M | $103M | 34.20% |
| 189 | Ligand Pharmaceuticals Incorporated | LGND:US | $5.8B | $291M | 33.70% |
| 190 | MedX Health Corp | MDX:V | $18M | $569,792 | 33.70% |
| 191 | BioCryst Pharmaceuticals Inc | BCRX:US | $2.2B | $941M | 33.60% |
| 192 | Vitalhub Corp | VHI:TO | $473M | $127M | 33.00% |
| 193 | Biofrontera Inc | BFRI:US | $17M | $46M | 32.90% |
| 194 | Ironwood Pharmaceuticals Inc | IRWD:US | $729M | $389M | 32.60% |
| 195 | CeriBell, Inc | CBLL:US | $931M | $102M | 32.50% |
| 196 | Supernus Pharmaceuticals Inc | SUPN:US | $2.5B | $830M | 32.40% |
| 197 | Quipt Home Medical Corp. | QIPT:TO | $221M | $265M | 32.00% |
| 198 | Establishment Labs Holdings Inc | ESTA:US | $2.1B | $246M | 31.70% |
| 199 | Corcept Therapeutics Incorporated | CORT:US | $12.7B | $831M | 31.70% |
| 200 | Alignment Healthcare LLC | ALHC:US | $1.7B | $4.6B | 31.60% |
Advertisement
Frequently Asked Questions
Which Canadian company ranks #1 by revenue growth (yoy) in Health Care?
As of September 23, 2026, Axe Compute Inc. (AGPU:US) ranks #1 in Health Care at 119772.90%.
How often is this ranking updated?
The table is rebuilt from live fundamentals throughout the day. This page currently shows data as of September 23, 2026.
How many companies are in this revenue growth (yoy) list?
This view shows 200 Canadian listings in Health Care. Canadian Depositary Receipts are hidden by default.
What is the difference between TSX and TSXV?
The Toronto Stock Exchange (TSX) lists larger established companies. The TSX Venture Exchange (TSXV) lists earlier-stage companies. Use the exchange filter to separate them.
Explore More Stock Rankings
Largest by Market Cap
Companies with the highest market capitalization
Largest by Revenue
Companies with the highest annual revenue
Highest Profit Margin
Most profitable companies by net margin
Highest Return on Equity
Companies generating the best returns for shareholders
Highest Return on Assets
Most efficient companies at using assets
Highest Dividend Yield
Top dividend-paying stocks
Fastest Earnings Growth
Companies with strongest year-over-year earnings growth